AltruBio
PrivateLast Round
Series B
May 21, 2024
Total Funding Raised
$288M
Company Overview
AltruBio is a clinical-stage biotechnology company that develops novel antibody therapeutics for immunological and inflammatory diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
AltruBio Comparables
Compare AltruBio with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Allianthera (Suzhou) Biopharmaceuticals Co., Ltd. | 78% | |
| Athos Therapeutics | 77% | |
| AnaptysBio, Inc. | 77% | |
AltruBio Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series B | May 21, 2024 | ||||
| Series A | Apr 15, 2021 | ||||
| VC Round | Aug 15, 2014 | ||||
| VC Round | Jun 22, 2012 |
Key People
Founding team and executive leadership
AltruBio Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Soleus Capital | Series B |
| RA Capital Management | Series B |
| CAM Capital | Series A |
| aMoon | Series B, Series A |
| BVF Partners L.P. | Series A |
| Blackstone Multi-Asset Investing | Series B |
| Blackstone Funds | Series B |
Market signals
Structured signals derived from secondary market and firmographic data.
- May 21, 2024
$225M round with participation from Blackstone Funds and aMoon.
AltruBio Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about AltruBio's valuation, stock price, and market status.